These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37012020)

  • 1. Epidemiology and Management of invasive infections among people who Use drugs (EMU): protocol for a prospective, multicentre cohort study.
    Attwood LO; Bryant M; Lee SJ; Vujovic O; Higgs P; Doyle JS; Stewardson AJ;
    BMJ Open; 2023 Apr; 13(4):e070236. PubMed ID: 37012020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Partial Oral Antibiotic Treatment for Persons Who Inject Drugs and Are Hospitalized With Invasive Infections.
    Marks LR; Liang SY; Muthulingam D; Schwarz ES; Liss DB; Munigala S; Warren DK; Durkin MJ
    Clin Infect Dis; 2020 Dec; 71(10):e650-e656. PubMed ID: 32239136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Harm reduction for the treatment of patients with severe injection-related infections: description of the Jackson SIRI Team.
    Serota DP; Tookes HE; Hervera B; Gayle BM; Roeck CR; Suarez E; Forrest DW; Kolber MA; Bartholomew TS; Rodriguez AE; Doblecki-Lewis S
    Ann Med; 2021 Dec; 53(1):1960-1968. PubMed ID: 34726095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opportunistic treatment of hepatitis C virus infection (OPPORTUNI-C): study protocol for a pragmatic stepped wedge cluster randomized trial of immediate versus outpatient treatment initiation among hospitalized people who inject drugs.
    Midgard H; Finbråten AK; Malme KB; Berg-Pedersen RM; Tanum L; Olsen IC; Bjørnestad R; Dalgard O
    Trials; 2020 Jun; 21(1):524. PubMed ID: 32539853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Second Heart Program-A multidisciplinary team supporting people who inject drugs with infective endocarditis: Protocol of a feasibility study.
    Lennox R; Lamarche L; Martin L; O'Shea T; Belley-Côté E; Cvetkovic A; Virag O; Whitlock R
    PLoS One; 2021; 16(10):e0256839. PubMed ID: 34710094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The burden of skin and soft tissue, bone and joint infections in an Australian cohort of people who inject drugs.
    Morgan B; Lancaster R; Boyagoda B; Ananda R; Attwood LO; Jacka D; Woolley I
    BMC Infect Dis; 2024 Mar; 24(1):299. PubMed ID: 38454356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Social and structural determinants of injecting-related bacterial and fungal infections among people who inject drugs: protocol for a mixed studies systematic review.
    Brothers TD; Lewer D; Bonn M; Webster D; Harris M
    BMJ Open; 2021 Aug; 11(8):e049924. PubMed ID: 34373309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of New Bloodstream Infections and Mortality Among People Who Inject Drugs With Infective Endocarditis.
    Tan C; Shojaei E; Wiener J; Shah M; Koivu S; Silverman M
    JAMA Netw Open; 2020 Aug; 3(8):e2012974. PubMed ID: 32785635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low mortality but increasing incidence of Staphylococcus aureus endocarditis in people who inject drugs: Experience from a Swedish referral hospital.
    Asgeirsson H; Thalme A; Weiland O
    Medicine (Baltimore); 2016 Dec; 95(49):e5617. PubMed ID: 27930590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards HCV elimination among people who inject drugs in Hai Phong, Vietnam: study protocol for an effectiveness-implementation trial evaluating an integrated model of HCV care (DRIVE-C: DRug use & Infections in ViEtnam-hepatitis C).
    Rapoud D; Quillet C; Pham Minh K; Vu Hai V; Nguyen Thanh B; Nham Thi Tuyet T; Tran Thi H; Molès JP; Vallo R; Michel L; Feelemyer J; Weiss L; Lemoine M; Vickerman P; Fraser H; Duong Thi H; Khuat Thi Hai O; Des Jarlais D; Nagot N; Laureillard D;
    BMJ Open; 2020 Nov; 10(11):e039234. PubMed ID: 33208326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicentre randomised double-blind placebo controlled trial of combination vancomycin and cefazolin surgical antibiotic prophylaxis: the Australian surgical antibiotic prophylaxis (ASAP) trial.
    Peel T; Astbury S; Cheng AC; Paterson D; Buising K; Spelman T; Tran-Duy A; de Steiger RS;
    BMJ Open; 2019 Nov; 9(11):e033718. PubMed ID: 31685516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of management priorities for invasive infections in people who inject drugs: highlighting the need for patient-centred multidisciplinary care.
    Attwood LO; McKechnie M; Vujovic O; Higgs P; Lloyd-Jones M; Doyle JS; Stewardson AJ
    Med J Aust; 2022 Jul; 217(2):102-109. PubMed ID: 35754144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial.
    Aflaki M; Flannery A; Ferreira JP; Cheng MP; Kronfli N; Marelli A; Zannad F; Brophy J; Afillalo J; Huynh T; Giannetti N; Bessissow A; Ezekowitz JA; Lopes RD; Ambrosy AP; Craig M; Sharma A
    Trials; 2021 Feb; 22(1):115. PubMed ID: 33546734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. M
    Martel-Laferrière V; Feaster DJ; Metsch LR; Schackman BR; Loignon C; Nosyk B; Tookes H; Behrends CN; Arruda N; Adigun O; Goyer ME; Kolber MA; Mary JF; Rodriguez AE; Yanez IG; Pan Y; Khemiri R; Gooden L; Sako A; Bruneau J
    Trials; 2022 Apr; 23(1):341. PubMed ID: 35461260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peer-mediated HIV assisted partner services to identify and link to care HIV-positive and HCV-positive people who inject drugs: a cohort study protocol.
    Monroe-Wise A; Mbogo L; Guthrie B; Bukusi D; Sambai B; Chohan B; Scott J; Cherutich P; Musyoki H; Bosire R; Dunbar M; Macharia P; Masyuko S; Wilkinson E; De Oliveira T; Ludwig-Barron N; Sinkele B; Herbeck J; Farquhar C
    BMJ Open; 2021 Apr; 11(4):e041083. PubMed ID: 33895711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid PrEscRiptions and usage After Surgery (OPERAS): protocol for a prospective multicentre observational cohort study of opioid use after surgery.
    TASMAN Collaborative Project Management Group
    BMJ Open; 2022 Nov; 12(11):e063577. PubMed ID: 36332960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Prospective, observational cohort study to identify neonates and children at risk of postdischarge mortality in Dar es Salaam, Tanzania and Monrovia, Liberia: the PPDM study protocol.
    Rees CA; Kisenge R; Ideh RC; Kamara J; Samma A; Godfrey E; Manji HK; Sudfeld CR; Westbrook A; Niescierenko M; Manji KP; Duggan CP
    BMJ Paediatr Open; 2022 Jan; 6(1):. PubMed ID: 35404835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
    Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
    Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.